PF-05381941

[1474022-02-0]

12352005

H302, H315, H319

MAP3K; p38 MAPK

Reference compound

MAPK/ERK Pathway

COVID-19-immunoregulation

Inflammation/Immunology

https://www.medchemexpress.com/pf-05381941.html

99.73

DMSO : 100 mg/mL (ultrasonic)

O=C(NC1=CC=C(OC2=CC=NC=C2)C(C)=C1)NC3=CC(C(C)(C)C)=NN3C4=CC=CC(C#N)=C4

C27H26N6O2

466.53

H302, H315, H319

[1]Kilty I, et al. TAK1 inhibition in the DFG-out conformation. Chem Biol Drug Des. 2013;82 (5) :500-505.

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

Reference compound1

No Development Reported

P38α